Dexamethasone  	Dexamethasone  	 NNP	B-NP
reduces  	reduces  	 VBZ	O
nausea  	nausea  	 VBN	O
and  	and  	 CC	O
vomiting  	vomiting  	 NN	O
but  	but  	 CC	O
not  	not  	 RB	O
pain  	pain  	 VBN	O
after  	after  	 IN	O
thyroid  	thyroid  	 JJ	B-NP
surgery 	surgery 	 NN	I-NP
:  	:  	 :	O
a  	a  	 DT	O
meta-analysis  	meta-analysis  	 JJ	B-NP
of  	of  	 IN	O
randomized  	randomized  	 FW	O
controlled  	controlled  	 FW	B-NP
trials  	trials  	 FW	I-NP
Postoperative  	Postoperative  	 FW	I-NP
nausea  	nausea  	 FW	I-NP
and  	and  	 CC	O
vomiting  	vomiting  	 NNS	O
( 	( 	 -LRB-	O
PONV 	PONV 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
common  	common  	 JJ	O
complication  	complication  	 NN	B-NP
after  	after  	 IN	O
thyroidectomy 	thyroidectomy 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
aim  	aim  	 NN	O
of  	of  	 IN	O
this  	this  	 DT	O
article  	article  	 NN	O
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
dexamethasone  	dexamethasone  	 NN	B-NP
for  	for  	 IN	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
PONV  	PONV  	 NNP	B-NP
and  	and  	 CC	O
pain  	pain  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
thyroidectomy 	thyroidectomy 	 NNS	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
performed  	performed  	 VBD	O
this  	this  	 DT	O
meta-analysis  	meta-analysis  	 JJ	B-NP
based  	based  	 VBN	O
on  	on  	 IN	O
the  	the  	 DT	O
QUORUM  	QUORUM  	 NNP	B-NP
( 	( 	 -LRB-	O
Quality  	Quality  	 NNP	O
of  	of  	 IN	O
Reporting  	Reporting  	 NNP	O
of  	of  	 IN	O
Meta-analyses 	Meta-analyses 	 NNP	B-NP
)  	)  	 -RRB-	O
guidelines 	guidelines 	 NNS	O
.  	.  	 .	O
Our  	Our  	 PRP$	O
study  	study  	 NN	O
included  	included  	 VBD	O
randomized  	randomized  	 VBN	B-NP
controlled  	controlled  	 VBN	I-NP
trials  	trials  	 NNS	I-NP
( 	( 	 -LRB-	O
RCTs 	RCTs 	 NNP	B-NP
)  	)  	 -RRB-	O
that  	that  	 IN	O
compared  	compared  	 VBN	O
preoperative  	preoperative  	 JJ	B-NP
single-dose  	single-dose  	 JJ	I-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	I-NP
dexamethasone  	dexamethasone  	 NN	I-NP
with  	with  	 IN	O
no  	no  	 DT	O
dexamethasone  	dexamethasone  	 NN	B-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
thyroidectomy 	thyroidectomy 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
primary  	primary  	 JJ	B-NP
outcome  	outcome  	 NN	I-NP
was  	was  	 VBD	O
occurrence  	occurrence  	 JJ	O
and  	and  	 CC	O
severity  	severity  	 NN	O
of  	of  	 IN	O
PONV 	PONV 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
the  	the  	 DT	O
secondary  	secondary  	 JJ	B-NP
outcomes  	outcomes  	 NNS	I-NP
included  	included  	 VBD	I-NP
pain 	pain 	 NN	I-NP
,  	,  	 ,	O
use  	use  	 NN	O
of  	of  	 IN	O
analgesics 	analgesics 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
steroid-related  	steroid-related  	 JJ	O
complications 	complications 	 NNS	B-NP
.  	.  	 .	O
Seven  	Seven  	 CD	O
RCTs  	RCTs  	 NN	B-NP
were  	were  	 VBD	O
included 	included 	 VBN	O
,  	,  	 ,	O
with  	with  	 IN	O
a  	a  	 DT	O
total  	total  	 NN	O
of  	of  	 IN	O
611  	611  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
A  	A  	 DT	O
statistically  	statistically  	 NN	O
and  	and  	 CC	O
clinically  	clinically  	 RB	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
in  	in  	 IN	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
and  	and  	 CC	O
severity  	severity  	 NN	O
of  	of  	 IN	O
PONV  	PONV  	 NNP	B-NP
was  	was  	 VBD	O
found  	found  	 VBN	O
in  	in  	 IN	O
favor  	favor  	 NN	O
of  	of  	 IN	O
dexamethasone  	dexamethasone  	 NNS	B-NP
( 	( 	 -LRB-	O
SMD 	SMD 	 NNP	B-NP
,  	,  	 ,	O
0.23 	0.23 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI 	CI 	 NNP	O
,  	,  	 ,	O
0.13-0.41 	0.13-0.41 	 NNP	O
;  	;  	 :	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.00001 	0.00001 	 NNP	O
;  	;  	 :	O
SMD 	SMD 	 NNP	B-NP
,  	,  	 ,	O
0.53 	0.53 	 CD	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI 	CI 	 NNP	O
,  	,  	 ,	O
-1.03  	-1.03  	 CD	O
to  	to  	 TO	O
-0.03 	-0.03 	 CD	O
;  	;  	 :	O
P=0.04 	P=0.04 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
there  	there  	 EX	O
was  	was  	 VBD	O
no  	no  	 DT	O
significant  	significant  	 JJ	O
difference  	difference  	 NN	O
in  	in  	 IN	O
reduction  	reduction  	 NN	O
of  	of  	 IN	O
pain  	pain  	 NN	B-NP
severity  	severity  	 NN	I-NP
and  	and  	 CC	O
analgesic  	analgesic  	 JJ	B-NP
consumption  	consumption  	 NN	I-NP
in  	in  	 IN	O
using  	using  	 VBG	O
dexamethasone  	dexamethasone  	 NNS	B-NP
( 	( 	 -LRB-	O
SMD 	SMD 	 NNP	B-NP
,  	,  	 ,	O
-0.83 	-0.83 	 NNP	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI 	CI 	 NNP	O
,  	,  	 ,	O
-1.85  	-1.85  	 CD	O
to  	to  	 TO	O
0.18 	0.18 	 CD	O
;  	;  	 :	O
P=0.14 	P=0.14 	 CD	O
;  	;  	 :	O
SMD 	SMD 	 NNP	B-NP
,  	,  	 ,	O
-0.19 	-0.19 	 NNP	O
;  	;  	 :	O
95 	95 	 CD	O
%  	%  	 NN	O
CI 	CI 	 NNP	O
,  	,  	 ,	O
-0.43  	-0.43  	 CD	O
to  	to  	 TO	O
0.04 	0.04 	 CD	O
;  	;  	 :	O
P=0.10 	P=0.10 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
No  	No  	 DT	O
steroid-related  	steroid-related  	 JJ	O
complications  	complications  	 NNS	B-NP
were  	were  	 VBD	O
noted 	noted 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
single  	single  	 JJ	O
preoperative  	preoperative  	 JJ	B-NP
administration  	administration  	 NN	I-NP
of  	of  	 IN	I-NP
dexamethasone  	dexamethasone  	 NN	I-NP
reduced  	reduced  	 VBD	O
the  	the  	 DT	O
incidence  	incidence  	 NN	O
and  	and  	 CC	O
severity  	severity  	 NN	O
of  	of  	 IN	O
PONV  	PONV  	 NNP	B-NP
but  	but  	 CC	O
not  	not  	 RB	O
pain  	pain  	 JJ	B-NP
severity  	severity  	 NN	I-NP
and  	and  	 CC	O
analgesic  	analgesic  	 JJ	B-NP
consumption  	consumption  	 NN	I-NP
in  	in  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
thyroidectomy 	thyroidectomy 	 NNS	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
studies  	studies  	 NNS	I-NP
with  	with  	 IN	O
a  	a  	 DT	O
larger  	larger  	 JJR	O
sample  	sample  	 NN	O
size  	size  	 NN	O
are  	are  	 VBP	O
needed  	needed  	 VBN	O
to  	to  	 TO	O
further  	further  	 RB	O
explore  	explore  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
dexamethasone  	dexamethasone  	 NN	B-NP
on  	on  	 IN	O
postoperative  	postoperative  	 JJ	B-NP
pain  	pain  	 NN	I-NP
severity  	severity  	 NN	I-NP
and  	and  	 CC	O
analgesic  	analgesic  	 JJ	B-NP
consumption 	consumption 	 NN	I-NP
.  	.  	 .	O
